Direct to Patient Minimal Risk Biospecimen and Data Collection Research
NCT07128966 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2026-05-05
Summary
This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.
Conditions
- Healthy
- Lupus
- Celiac
- Kidney Disease
- Chronic
- Dermatologic
Interventions
- OTHER
-
Observation
This is non-interventional, observational only
Sponsors & Collaborators
-
Joined Bio
lead INDUSTRY
Principal Investigators
-
Chris Ianelli, MD · Joined Bio
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2035-09-01
- Completion
- 2036-09-01
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
NCT03562065 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus
NCT06694298 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
NCT01992666 ·Status: COMPLETED ·Phase: NA
-
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
NCT07185269 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus
NCT05791799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057
NCT00712933 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
NCT06064929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222 ·Status: UNKNOWN
-
A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus
NCT05796206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
NCT06106906 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants
NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02
NCT00583362 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus
NCT02411136 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
NCT02293161 ·Status: COMPLETED ·Phase: PHASE1
-
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
NCT01499355 ·Status: TERMINATED ·Phase: PHASE2
-
Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
NCT00908986 ·Status: WITHDRAWN ·Phase: NA
-
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
NCT02885610 ·Status: COMPLETED ·Phase: PHASE2
-
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
NCT02338999 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
NCT00004665 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients
NCT07183007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
NCT02962960 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of DS-7011a in Patients With Systemic Lupus Erythematosus
NCT05638802 ·Status: COMPLETED ·Phase: PHASE1/PHASE2